14–19 May 2023
Hotel Hermitage, La Biodola Bay, Elba Island, Italy
Europe/Rome timezone

Multilevel X-ray imaging approach to assess the sequential evolution of multi-organ damage in neurodegenerative diseases

16 May 2023, 20:00
30m
Hotel Hermitage, La Biodola Bay, Elba Island, Italy

Hotel Hermitage, La Biodola Bay, Elba Island, Italy

Biodola Bay 57037 Portoferraio (LI) Isola d’Elba - Italy
Oral Bioimaging

Speaker

Dr Francesca Palermo (Institute of Nanotechnology - CNR)

Description

The 3D complexity of biological tissues and intricate structural-functional connections call for state-of-the-art X-ray imaging approaches. Unlike other imaging techniques, X-ray phase-contrast tomography (XPCT) offers a highly sensitive 3D imaging approach to investigate different disease-relevant networks at levels ranging from the single cell through to the whole organ. We present here a concomitant study of the evolution of tissue damage and inflammation in different organs affected by the disease in the murine model for multiple sclerosis, a demyelination autoimmune disorder of the central nervous system. XPCT identifies and monitors structural and cellular alterations throughout the central nervous system, but also in the gut, and eye, of mice induced to develop multiple sclerosis-like disease and sacrificed at pre-symptomatic and symptomatic time points. This approach rests on a multiscale analysis to detect early appearance of imaging indicators potentially acting as biomarkers that can predict the disease. The longitudinal data obtained permit an original evaluation of the sequential evolution of multi-organ damages in the murine model showing the disease development and progression, of relevance for the human case.

Select Topic 1 Bioimaging
Select Topic 2 Unmet Medical Needs

Primary author

Dr Francesca Palermo (Institute of Nanotechnology - CNR)

Co-authors

Dr Alessia Sanna (Institute of Nanotechnology - CNR) Dr Lorenzo Massimi (Institute of Nanotechnology - CNR) Dr Michela Fratini (Institute of Nanotechnology - CNR) Dr Inna Bukreeva (Institute of Nanotechnology - CNR) Dr Nicole Kerlero de Rosbo (Institute of Nanotechnology - CNR) Dr Alessia Cedola (Institute of Nanotechnology - CNR)

Presentation materials